Protagonist Therapeutics, Inc (PTGX) Insider Trading

Name: Protagonist Therapeutics, Inc (PTGX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Ali Asif (Chief Financial Officer): Exercise/Conversion of 9,229 shares, $359.7K.

Get alerted when insiders trade PTGX

Email address

Loading company data...

Beta

Loading company details...

Beta